P
PT UBC Medical Indonesia Tbk
IDX:LABS
PT UBC Medical Indonesia Tbk
IDX:LABS
Price:
164
IDR
3.14%
Market Closed
Market Cap:
Rp647.8B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
P
|
PT UBC Medical Indonesia Tbk
IDX:LABS
|
ID |
|
Centrotherm International AG
F:CTNK
|
DE |
|
HomeStreet Inc
NASDAQ:HMST
|
US |
|
Almacenes Exito SA
NYSE:EXTO
|
CO |
|
LM Funding America Inc
NASDAQ:LMFA
|
US |
|
Enzon Pharmaceuticals Inc
OTC:ENZN
|
US |
|
Thomson Medical Group Ltd
SGX:A50
|
SG |
|
X
|
Xinjiang Tianfu Energy Co Ltd
SSE:600509
|
CN |
|
NH Foods Ltd
TSE:2282
|
JP |
|
Myer Holdings Ltd
ASX:MYR
|
AU |
|
Positive Physicians Holdings Inc
OTC:PPHI
|
US |
|
Nichols PLC
LSE:NICL
|
UK |
|
A
|
Attica Publications SA
ATHEX:ATEK
|
GR |
|
Linde India Ltd
NSE:LINDEINDIA
|
IN |
|
Digital Brand Media & Marketing Group Inc
OTC:DBMM
|
US |
Multiples-Based Value
The Multiples-Based Value of one LABS stock under the Base Case scenario is hidden IDR. Compared to the current market price of 164 IDR, PT UBC Medical Indonesia Tbk is hidden .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
LABS Multiples-Based Value
LOCKED
Multiples Across Competitors
LABS Competitors Multiples
PT UBC Medical Indonesia Tbk Competitors
PT UBC Medical Indonesia Tbk Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| ID |
P
|
PT UBC Medical Indonesia Tbk
IDX:LABS
|
647.8B IDR | 3.7 | 69.6 | 41.6 | 41.6 | |
| US |
|
Mckesson Corp
NYSE:MCK
|
107.4B USD | 0.3 | 24.8 | 17.4 | 19.5 | |
| US |
|
Cencora Inc
NYSE:COR
|
62.7B USD | 0.2 | 38.6 | 13.7 | 17.3 | |
| US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
62.3B USD | 0.2 | 38.3 | 13.6 | 17.1 | |
| US |
|
Cardinal Health Inc
NYSE:CAH
|
50.9B USD | 0.2 | 30.6 | 14.8 | 19.2 | |
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
31.1B AUD | 2.7 | 34.1 | 25.3 | 25.3 | |
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
64.1B CNY | 0.2 | 11.2 | 8.7 | 8.7 | |
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
63.6B CNY | 1.5 | 17.2 | 13.3 | 13.3 | |
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
8.8B USD | 0.7 | 22 | 10.9 | 15.3 | |
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
67.1B HKD | 0.1 | 8.4 | 0.8 | 1 | |
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW | 5.9 | 89.6 | 59.9 | 61.9 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
